Home › NDC Lookup › RxCUI directory › RxCUI 198070

Penicillamine 250 MG Oral Capsule — RxCUI 198070

RxNorm drug concept · Semantic clinical drug
RxCUI 198070 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198070
Official namePenicillamine 250 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)39 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Penicillamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's one of the most important parts of staying safe on penicillamine. This drug can affect your bone marrow and reduce blood cell counts — sometimes severely — and it can also c...
  • Why does my doctor keep ordering so many blood tests while I'm on this medication?
  • Unfortunately, no — even a small snack matters here. Food, milk, antacids, and iron all significantly reduce how much penicillamine your body absorbs, and they can even inactivate...
  • Why do I have to take it on an empty stomach? Can I just take it with a small snack?
📖 Read our full Penicillamine guide →

🕸️ Concept Web — How Penicillamine 250 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Penicillamine 250 MG Oral Capsule RxCUI 198070

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Penicillamine 7975
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aagylur 2723903
    • Cuprimine 202724
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Penicillamine Oral Capsule 373257
    • Penicillamine Oral Product 1164762
    • Penicillamine Pill 1164763
    • Penicillamine Oral Capsule [Aagylur] 2723907
    • Penicillamine Oral Capsule [Cuprimine] 366736
    • Aagylur Oral Product 2723905
    • Aagylur Pill 2723906
    • Cuprimine Oral Product 1173080
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Penicillamine 250 MG SCDC · 316454
  • Penicillamine Oral Capsule SCDF · 373257
  • Penicillamine Oral Product SCDG · 1164762
  • Penicillamine Pill SCDG · 1164763

Brand-Name Concepts

  • Penicillamine 250 MG Oral Capsule [Aagylur] SBD · 2723908
  • Penicillamine 250 MG Oral Capsule [Cuprimine] SBD · 207369
  • Penicillamine 250 MG [Aagylur] SBDC · 2723904
  • Penicillamine 250 MG [Cuprimine] SBDC · 568137
  • Penicillamine Oral Capsule [Aagylur] SBDF · 2723907
  • Penicillamine Oral Capsule [Cuprimine] SBDF · 366736
  • Aagylur Oral Product SBDG · 2723905
  • Aagylur Pill SBDG · 2723906
  • Cuprimine Oral Product SBDG · 1173080
  • Cuprimine Pill SBDG · 1173081

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 198070 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-4171-01 100 CAPSULE in 1 BOTTLE (0591-4171-01) Penicillamine Actavis Pharma, Inc. 2019-06-25
25010-0705-15 100 CAPSULE in 1 BOTTLE (25010-705-15) Cuprimine Bausch Health US, LLC 1970-12-04
43598-0634-01 100 CAPSULE, GELATIN COATED in 1 BOTTLE (43598-634-01) Penicillamine Dr. Reddy's Laboratories Inc. 2020-08-04
49884-0146-01 100 CAPSULE in 1 BOTTLE (49884-146-01) Penicillamine Endo USA, Inc. 2020-01-08
51991-0974-01 100 CAPSULE in 1 BOTTLE (51991-974-01) Penicillamine Breckenridge Pharmaceutical, Inc. 2021-11-12
68475-0201-01 100 CAPSULE in 1 BOTTLE (68475-201-01) Penicillamine Navinta LLC 2022-01-01
70010-0907-01 100 CAPSULE in 1 BOTTLE (70010-907-01) Penicillamine Granules Pharmaceuticals Inc. 2020-12-21
70709-0102-10 100 CAPSULE in 1 BOTTLE (70709-102-10) AAGYLUR Cycle Pharmaceuticals Ltd. 2025-09-25
71205-0916-00 100 CAPSULE in 1 BOTTLE (71205-916-00) Penicillamine Proficient Rx LP 2021-07-08
Observed labelers: Actavis Pharma, Inc. (1) · Bausch Health US, LLC (1) · Breckenridge Pharmaceutical, Inc. (1) · Cycle Pharmaceuticals Ltd. (1) · Dr. Reddy's Laboratories Inc. (1) · Endo USA, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.